Disease | thromboembolism |
Phenotype | C0006142|breast cancer |
Sentences | 8 |
PubMedID- 24902734 | Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a danish population-based cohort study. |
PubMedID- 22859911 | Risk of venous thromboembolism in women with breast cancer, with pooled incidence rates and 95% confidence intervals obtained from random effects meta-analysis. |
PubMedID- 20658564 | Like other serms, arzoxifene decreased vertebral fractures and invasive breast cancer while the risk of venous thromboembolic events increased. |
PubMedID- 22959707 | Tamoxifen-associated thromboembolism in breast cancer. |
PubMedID- 23497923 | Relationship between factor v leiden mutation and venous thromboembolism in patients with breast cancer treated with tamoxifen. |
PubMedID- 21343938 | Tamoxifen increases the risk of venous thromboembolism in women with breast cancer, but its relationship to stroke is uncertain. |
PubMedID- 24452534 | This positive phenomenon is observed in both healthy volunteers and in patients who run the risk of developing either atherosclerosis [18, 19] or thromboembolic disorders associated with breast cancer [20]. |
PubMedID- 25841596 | Certain medical conditions, including hypertension, migraine, breast cancer, and risk of venous thromboembolism (vte), present contraindications. |
Page: 1